A detailed history of Monarch Partners Asset Management LLC transactions in Innoviva, Inc. stock. As of the latest transaction made, Monarch Partners Asset Management LLC holds 281,595 shares of INVA stock, worth $5.39 Million. This represents 1.14% of its overall portfolio holdings.

Number of Shares
281,595
Previous 305,640 7.87%
Holding current value
$5.39 Million
Previous $3.55 Million 5.16%
% of portfolio
1.14%
Previous 1.07%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 02, 2023

SELL
$11.8 - $13.78 $283,731 - $331,340
-24,045 Reduced 7.87%
281,595 $3.73 Million
Q3 2022

Oct 31, 2022

BUY
$11.61 - $15.22 $828,721 - $1.09 Million
71,380 Added 30.47%
305,640 $3.55 Million
Q2 2022

Jul 20, 2022

BUY
$14.32 - $19.88 $3.35 Million - $4.66 Million
234,260 New
234,260 $3.46 Million

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.33B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Monarch Partners Asset Management LLC Portfolio

Follow Monarch Partners Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monarch Partners Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Monarch Partners Asset Management LLC with notifications on news.